8-18060379-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_177924.5(ASAH1):c.786-676G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.401 in 152,348 control chromosomes in the GnomAD database, including 12,954 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.40 ( 12919 hom., cov: 32)
Exomes 𝑓: 0.38 ( 35 hom. )
Consequence
ASAH1
NM_177924.5 intron
NM_177924.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.430
Publications
12 publications found
Genes affected
ASAH1 (HGNC:735): (N-acylsphingosine amidohydrolase 1) This gene encodes a member of the acid ceramidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. Processing of this preproprotein generates alpha and beta subunits that heterodimerize to form the mature lysosomal enzyme, which catalyzes the degradation of ceramide into sphingosine and free fatty acid. This enzyme is overexpressed in multiple human cancers and may play a role in cancer progression. Mutations in this gene are associated with the lysosomal storage disorder, Farber lipogranulomatosis, and a neuromuscular disorder, spinal muscular atrophy with progressive myoclonic epilepsy. [provided by RefSeq, Oct 2015]
ASAH1 Gene-Disease associations (from GenCC):
- ASAH1-related sphingolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Farber lipogranulomatosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- spinal muscular atrophy-progressive myoclonic epilepsy syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.64 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.401 AC: 60892AN: 151838Hom.: 12903 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
60892
AN:
151838
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.375 AC: 147AN: 392Hom.: 35 Cov.: 0 AF XY: 0.369 AC XY: 87AN XY: 236 show subpopulations
GnomAD4 exome
AF:
AC:
147
AN:
392
Hom.:
Cov.:
0
AF XY:
AC XY:
87
AN XY:
236
show subpopulations
African (AFR)
AF:
AC:
0
AN:
2
American (AMR)
AF:
AC:
16
AN:
20
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
4
East Asian (EAS)
AF:
AC:
8
AN:
12
South Asian (SAS)
AF:
AC:
3
AN:
6
European-Finnish (FIN)
AF:
AC:
1
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
110
AN:
332
Other (OTH)
AF:
AC:
7
AN:
12
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.524
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.401 AC: 60958AN: 151956Hom.: 12919 Cov.: 32 AF XY: 0.409 AC XY: 30374AN XY: 74282 show subpopulations
GnomAD4 genome
AF:
AC:
60958
AN:
151956
Hom.:
Cov.:
32
AF XY:
AC XY:
30374
AN XY:
74282
show subpopulations
African (AFR)
AF:
AC:
15497
AN:
41434
American (AMR)
AF:
AC:
8432
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
1790
AN:
3470
East Asian (EAS)
AF:
AC:
3356
AN:
5128
South Asian (SAS)
AF:
AC:
3170
AN:
4808
European-Finnish (FIN)
AF:
AC:
3232
AN:
10568
Middle Eastern (MID)
AF:
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24159
AN:
67964
Other (OTH)
AF:
AC:
853
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1767
3535
5302
7070
8837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2118
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.